Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Decreases By 46.8%

Autonomix Medical, Inc. (NASDAQ:AMIX) was the recipient of a significant decrease in short interest in the month of June. As of June 15th, there was short interest totaling 344,031 shares, a decrease of 46.8% from the May 31st total of 646,074 shares. Based on an average daily trading volume, of 146,755 shares, the short-interest ratio is presently 2.3 days. Approximately 5.3% of the company’s stock are short sold.

Autonomix Medical Price Performance

Shares of AMIX traded up $0.07 during mid-day trading on Wednesday, reaching $6.30. The company’s stock had a trading volume of 2,267 shares, compared to its average volume of 42,451. Autonomix Medical has a 12-month low of $4.20 and a 12-month high of $55.44. The stock has a market cap of $3.40 million, a PE ratio of -0.08 and a beta of -1.43. The company’s 50 day moving average is $7.72 and its 200 day moving average is $8.94.

Analysts Set New Price Targets

A number of research analysts recently issued reports on AMIX shares. Zacks Research upgraded shares of Autonomix Medical to a “hold” rating in a research note on Tuesday, June 2nd. Weiss Ratings raised shares of Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a research report on Tuesday, June 23rd. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Autonomix Medical has a consensus rating of “Hold” and an average target price of $42.00.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.